Myeloid Disorders

In this video, Tania Jain, MBBS, director of the Immune Effector Cell Therapy Program and associate professor of oncology at Johns Hopkins University, discussed the different approaches to treating different types of MPNs, like myelofibrosis, essential thrombocythemia and polycythemia vera.

In this video, Akriti Jain, MD, discusses whether patients with acute myeloid leukemia with IDH mutations should be treated with IDH inhibitors up front compared to venetoclaxcontaining regimens.

In this video, Akriti Jain, MD, discusses the results of a study on treatment patterns and outcomes for patients with acute myeloid Leukemia , which showed that outcomes improved over the past decade.